Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
2 other identifiers
observational
44
1 country
3
Brief Summary
The objective of the study is to determine the relative roles for various testing modalities in the diagnosis and prognosis of mild traumatic brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2014
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2014
CompletedFirst Posted
Study publicly available on registry
February 24, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedNovember 8, 2017
November 1, 2017
3.4 years
February 18, 2014
November 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in objective measures of brain function (MEG/EEG, blood biomarkers)
For MEG/EEG, resting state analyses of brain function will be conducted to include frequency band analyses localizing, for example, delta slow wave activity, and establishing functional connectivity scores at three time points post injury (day 1, day 14, day 30). For blood biomarkers, serum levels in approximately ten biomarkers will be measured to determine amount in each and if changes occur at three time points post-injury.
Day 1, day 14, and day 30 post-injury
Secondary Outcomes (1)
Change in anatomical measures of brain function (DTI, SWI)
Day 1, day 14, and day 30 post-injury
Study Arms (2)
Mild traumatic brain injury (mTBI)
Patients admitted to Huntington Memorial Hospital (HMH), Pasadena CA, Emergency Department (ED) diagnosed with mTBI by history (alteration of consciousness, post-traumatic amnesia, loss of consciousness) and normal brain computed tomography (CT).
Control
Patients admitted to HMH ED for minor extremity trauma (sprains) and no evidence of mTBI
Eligibility Criteria
Study participants (control, mTBI) will be referred by the Huntington Hospital Emergency Department staff. ED staff will determine the eligibility criteria. If consent is achieved, testing will occur at pre-determined times: 1 day, 14 days, and 30 days post-injury.
You may qualify if:
- \. Civilian (non-military) presenting to HMH ED.
You may not qualify if:
- Prior history of diagnosed TBI.
- Other significant non-head injury/trauma or open wound.
- Other significant medical co-morbidities, such as heart disease or cancer.
- Self-reported current use or substances contributing to ED visit (e.g. illicit drugs, medications, alcohol abuse).
- Currently diagnosed psychological condition (e.g. depression, PTSD).
- Medications for psychological or neurological disorder.
- Any implanted metal, such as medical device or braces on teeth.
- Injury to the back or other injury that will make it difficult for the participant to tolerate tests.
- Injury to dominant arm that would cause difficulty using computer or responding to stimuli during functional imaging.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Huntington Medical Research Institutes
Pasadena, California, 91101, United States
HMRI
Pasadena, California, 91105, United States
Molecular Neurology Program
Pasadena, California, 91105, United States
Related Publications (6)
Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med. 2008 Jan 31;358(5):453-63. doi: 10.1056/NEJMoa072972. Epub 2008 Jan 30.
PMID: 18234750BACKGROUNDBigler ED. Neuropsychology and clinical neuroscience of persistent post-concussive syndrome. J Int Neuropsychol Soc. 2008 Jan;14(1):1-22. doi: 10.1017/S135561770808017X.
PMID: 18078527BACKGROUNDLewine JD, Davis JT, Bigler ED, Thoma R, Hill D, Funke M, Sloan JH, Hall S, Orrison WW. Objective documentation of traumatic brain injury subsequent to mild head trauma: multimodal brain imaging with MEG, SPECT, and MRI. J Head Trauma Rehabil. 2007 May-Jun;22(3):141-55. doi: 10.1097/01.HTR.0000271115.29954.27.
PMID: 17510590BACKGROUNDHuang MX, Theilmann RJ, Robb A, Angeles A, Nichols S, Drake A, D'Andrea J, Levy M, Holland M, Song T, Ge S, Hwang E, Yoo K, Cui L, Baker DG, Trauner D, Coimbra R, Lee RR. Integrated imaging approach with MEG and DTI to detect mild traumatic brain injury in military and civilian patients. J Neurotrauma. 2009 Aug;26(8):1213-26. doi: 10.1089/neu.2008.0672.
PMID: 19385722BACKGROUNDPelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma. 2004 Nov;57(5):1006-12. doi: 10.1097/01.ta.0000108998.48026.c3.
PMID: 15580024BACKGROUNDVos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004 Apr 27;62(8):1303-10. doi: 10.1212/01.wnl.0000120550.00643.dc.
PMID: 15111666BACKGROUND
Biospecimen
Blood will be retained for future analysis.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael G Harrington, MB
Huntington Medical Research Institutes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
February 18, 2014
First Posted
February 24, 2014
Study Start
March 1, 2014
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
November 8, 2017
Record last verified: 2017-11